Hypersensitivity reaction to balsalazide.
作者信息
Adhiyaman V, Vaishnavi A, Froese S
机构信息
Withybush General Hospital, Haverfordwest, Pembrokeshire SA61 2PZ.
出版信息
BMJ. 2000 Mar 4;320(7235):613. doi: 10.1136/bmj.320.7235.613.
Abstract
摘要
相似文献
1
Hypersensitivity reaction to balsalazide.对巴柳氮的超敏反应。
BMJ. 2000 Mar 4;320(7235):613. doi: 10.1136/bmj.320.7235.613.
2
Drug points: Hypersensitivity reaction to balsalazide.用药要点：对巴柳氮过敏反应。
BMJ. 2001 Sep 1;323(7311):489. doi: 10.1136/bmj.323.7311.489.
3
Oral balsalazide (Colazal) for ulcerative colitis.
Med Lett Drugs Ther. 2001 Jul 23;43(1109):62-3.
4
Balsalazide disodium.
Am J Health Syst Pharm. 2002 Jan 1;59(1):27.
5
Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.口服美沙拉嗪（艾迪莎）和巴柳氮等摩尔剂量5-氨基水杨酸酯的比较药代动力学：一项在健康志愿者中进行的随机、单剂量、交叉研究。
Aliment Pharmacol Ther. 2004 May 15;19(10):1089-98. doi: 10.1111/j.1365-2036.2004.01964.x.
6
Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.在改善急性轻至中度溃疡性结肠炎的体征和症状方面，巴柳氮比美沙拉嗪起效更快。
Am J Gastroenterol. 2002 Dec;97(12):3078-86. doi: 10.1111/j.1572-0241.2002.07103.x.
7
A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.一项关于巴柳氮（6.75克）、巴柳氮（2.25克）和美沙拉嗪（2.4克）治疗轻至中度活动性溃疡性结肠炎的随机、双盲、剂量反应比较研究。
Am J Gastroenterol. 2002 Jun;97(6):1398-407. doi: 10.1111/j.1572-0241.2002.05781.x.
8
Balsalazide and azathiprine or 6-mercaptopurine: evidence for a potentially serious drug interaction.
Gastroenterology. 1999 Jun;116(6):1505-6. doi: 10.1016/s0016-5085(99)70524-x.
9
Treatment of ulcerative colitis with balsalazide: response to Drs Johnson, Green, and Pruitt.
Am J Gastroenterol. 2003 Mar;98(3):697-8. doi: 10.1111/j.1572-0241.2003.07323.x.
10
Safety of balsalazide therapy in the treatment of inflammatory bowel disease.巴柳氮治疗炎症性肠病的安全性。
Rev Gastroenterol Disord. 2005 Summer;5(3):135-41.
引用本文的文献
1
5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review.5-氨基水杨酸相关性心肌炎和心包炎：一项叙述性综述
Can J Hosp Pharm. 2016 Nov-Dec;69(6):466-472. Epub 2016 Dec 23.
2
5-ASA induced recurrent myopericarditis and cardiac tamponade in a patient with ulcerative colitis.5-氨基水杨酸在一名溃疡性结肠炎患者中诱发复发性心肌心包炎和心脏压塞。
Dig Dis Sci. 2013 Aug;58(8):2148-50. doi: 10.1007/s10620-013-2566-4. Epub 2013 Jan 30.
3
Stress degradation studies and development of stability-indicating TLC-densitometry method for determination of prednisolone acetate and chloramphenicol in their individual and combined pharmaceutical formulations.应力降解研究及用于测定醋酸泼尼松龙和氯霉素及其复方制剂中含量的稳定性指示薄层色谱-密度测定法的开发。
Chem Cent J. 2012 Jan 22;6(1):7. doi: 10.1186/1752-153X-6-7.
本文引用的文献
1
Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.口服5-氨基水杨酸治疗溃疡性结肠炎，包括对柳氮磺胺吡啶有不良反应的患者。
Am J Gastroenterol. 1988 Jan;83(1):15-9.
2
Sulphasalazine-induced lupus-like syndrome with cardiac tamponade in a patient with ulcerative colitis.一名溃疡性结肠炎患者出现柳氮磺胺吡啶诱发的狼疮样综合征并伴有心脏压塞。
Am J Gastroenterol. 1989 Jan;84(1):85-6.
3
Pericardial effusion during treatment with 5-aminosalicylic acid in a patient with Crohn's disease.
Am J Gastroenterol. 1990 Mar;85(3):332-3.
4
Mesalazine induced lupus-like syndrome.美沙拉嗪诱发的狼疮样综合征。
BMJ. 1992 Jul 18;305(6846):159. doi: 10.1136/bmj.305.6846.159-b.
5
Sulphasalazine-induced lupus syndrome in ulcerative colitis.溃疡性结肠炎中柳氮磺胺吡啶诱发的狼疮综合征。
Br Med J. 1977 Nov 5;2(6096):1188-9. doi: 10.1136/bmj.2.6096.1188.
Zotero 插件